NCT05334134|Unknown
COVID-19: Immunological Mechanisms in Multisystem Inflammatory Syndrome in Children
Immunological Mechanisms in Multisystem Inflammatory Syndrome in Children
Loading search results
Immunological Mechanisms in Multisystem Inflammatory Syndrome in Children
Sponsor study identifier
observational
300
1 country
1
Study Start
February 1, 2020
Actual (reported)Primary Completion
December 31, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 30, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
This study seeks to explore immunological mechanisms in patients with Multisystem Inflammatory Syndrome in Children (MIS-C) to improve the understanding of this pathogenesis of this disease. In a cohort of MIS-C patients diagnosed during the Wild type, Alpha, Delta and Omicron waves, research samples will be analyzed for whole-blood RNA expression, proteomics, inflammatory cytokines, cellular immune populations, autoantibodies, as well as host genetic markers.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 30, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 1, 2020
Actual (reported)March 19, 2022
Actual (reported)April 19, 2022
Actual (reported)December 31, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
June 30, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Immunological mechanisms in MIS-C
Whole-blood RNA expression at admission and change during recovery
Day 0-3 and up to during 24 weeks
Patients fulfilling the diagnostic critieria of MIS-C, according to the CDC
Ulrikka Nygaard
Copenhagen, 2100, Denmark
Blood
Ulrikka Nygaard, MD PhD
Copenhagen University Hospital, Rigshospitalet
First Submitted
March 19, 2022
First Posted
April 19, 2022
Study Start
February 1, 2020
Actual (reported)Primary Completion
December 31, 2022
Estimated (date passed)Long COVID Kids DK - Investigating Long-term Covid-19
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 30, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
April 19, 2022
Record last verified: 2022-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: